Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Randomized, Parallel, Double-Blind, Vehicle Controlled Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In The Field-Directed Treatment Of Actinic Keratoses Grade I To II (Field Cancerization)

NCT02289768 is registered in ClinicalTrials.gov with Almirall, S.A. as lead sponsor.

NCT NCT02289768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02289768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Randomized, Parallel, Double-Blind, Vehicle Controlled Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In The Field-Directed Treatment Of Actinic Keratoses Grade I To II (Field Cancerization)
Lead sponsor
Almirall, S.A.
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2014
Completion date
September 30, 2015
Enrollment
166 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis